...
首页> 外文期刊>Cell death & disease. >Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination
【24h】

Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination

机译:细胞IAP蛋白和LUBAC差异调节坏死相关的RIP1泛素化。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Necroptosis is a caspase-independent regulated type of cell death that relies on receptor-interacting protein kinases RIP1 (receptor-interacting protein kinases 1) and RIP3. Tumor necrosis factor- α (TNF α )-stimulated assembly of the TNFR1 (TNF receptor 1)-associated signaling complex leads to the recruitment of RIP1, whose ubiquitination is mediated by the cellular inhibitors of apoptosis (c-IAPs). Translocation of RIP1 to the cytoplasm and association of RIP1 with the necrosome is believed to correlate with deubiquitination of RIP1. However, we found that RIP1 is ubiquitinated with K63 and linear polyubiquitin chains during TNF α , IAP antagonist BV6 and caspase inhibitor zVAD-fmk-induced necroptotic signaling. Furthermore, ubiquitinated RIP1 is associated with the necrosome, and RIP1 ubiquitination in the necrosome coincides with RIP3 phosphorylation. Both cellular IAPs and LUBAC (linear ubiquitin chain assembly complex) modulate RIP1 ubiquitination in IAP antagonist-treated necrotic cells, but they use different mechanisms. c-IAP1 regulates RIP1 recruitment to the necrosome without directly affecting RIP1 ubiquitination, whereas HOIP and HOIL1 mediate linear ubiquitination of RIP1 in the necrosome, but are not essential for necrosome formation. Knockdown of the E3 ligase c-IAP1 decreased RIP1 ubiquitination, necrosome assembly and necroptosis induced by TNF α , BV6 and zVAD-fmk. c-IAP1 deficiency likely decreases necroptotic cell death through the activation of the noncanonical NF- κ B pathway and consequent c-IAP2 upregulation. The ability to upregulate c-IAP2 could determine whether c-IAP1 absence will have a positive or negative impact on TNF α -induced necroptotic cell death and necrosome formation. Collectively, these results reveal unexpected complexity of the roles of IAP proteins, IAP antagonists and LUBAC in the regulation of necrosome assembly.
机译:坏死病是依赖于与受体相互作用的蛋白激酶RIP1(与受体相互作用的蛋白激酶1)和RIP3的一种不依赖胱天蛋白酶的调节型细胞死亡。肿瘤坏死因子-α(TNFα)刺激的TNFR1(TNF受体1)相关信号复合物的组装导致RIP1的募集,其泛素化由细胞凋亡的细胞抑制剂(c-IAP)介导。认为RIP1易位至细胞质以及RIP1与坏死体的缔合与RIP1的去泛素化有关。但是,我们发现RIP1在TNFα,IAP拮抗剂BV6和半胱天冬酶抑制剂zVAD-fmk诱导的坏死性信号转导过程中被K63和线性多聚泛素链泛素化。此外,泛素化的RIP1与坏死体相关,而坏死体中的RIP1泛素化与RIP3磷酸化相吻合。细胞IAP和LUBAC(线性泛素链组装复合体)均可调节IAP拮抗剂治疗的坏死细胞中的RIP1泛素化,但它们使用不同的机制。 c-IAP1调节RIP1募集至坏死体而不直接影响RIP1泛素化,而HOIP和HOIL1介导坏死体中RIP1的线性泛素化,但对于坏死体形成不是必需的。敲低E3连接酶c-IAP1减少了TNFα,BV6和zVAD-fmk诱导的RIP1泛素化,坏死性组装和坏死性坏死。 c-IAP1缺乏症可能通过激活非规范性NF-κB通路和随之而来的c-IAP2上调来减少坏死性细胞死亡。上调c-IAP2的能力可以确定c-IAP1的缺失对TNFα诱导的坏死性细胞死亡和坏死体形成有正面还是负面影响。总的来说,这些结果揭示了IAP蛋白,IAP拮抗剂和LUBAC在调节坏死组装中作用的意想不到的复杂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号